Author

D. Bossi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

L. Lanfrancone· 2 shared P. G. Pelicci· 2 shared A. Alimonti· 1 shared A. Carugo· 1 shared A. Mutti· 1 shared A. Rinaldi· 1 shared A. Vallerga· 1 shared C. Balestrieri· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

L. Lanfrancone

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

IN VIVO ISOLATION OF A QUIESCENT MELANOMA POPULATION WITH INVASIVE PROPERTIES UNVEILS A TRANSCRIPTIONAL REPROGRAMMING DRIVEN BY THE TUMOR NICHE

L. Lanfrancone, F. Lotti, M. Meliksetyan, M. Malferrari, N. Quaresima, S. Rapino, V. Mollo, I. Ferrarotto, T. Vlachou, D. Bossi, P. G. Pelicci, L. Luzi

The paper isolates a quiescent melanoma population in vivo, showing it has invasive properties and undergoes transcriptional reprogramming driven by the tumor niche.

bioRxiv · Jul 31, 2023 · PreprintCancer Biology

Dual Functions of SPOP and ERG Dictate Androgen Therapy Responses in Prostate Cancer

T. Bernasocchi, G. El tekle, M. Bolis, A. Mutti, A. Vallerga, L. P. Brandt, F. Spriano, T. Svinkina, M. Zoma, V. Ceserani, A. Rinaldi, H. Janouskova, D. Bossi, M. Cavalli, S. Mosole, , J. P. P. Theurillat

This study shows that SPOP and ERG mutations in prostate cancer have opposing effects on androgen receptor signaling and therapy response.

bioRxiv · Jul 8, 2020Cancer Biology

WDR5 regulates epithelial-to-mesenchymal transition in breast cancer cells via TGFB

S. Punzi, C. Balestrieri, C. D'Alesio, D. Bossi, G. I. Dellino, E. Gatti, G. Pruneri, C. Criscitiello, A. Carugo, G. Curigliano, G. Natoli, P. G. Pelicci, L. Lanfrancone

This study shows WDR5 promotes EMT in breast cancer by inhibiting TGFβ signaling, leading to increased metastatic potential and drug resistance.

bioRxiv · Jun 16, 2018 · PreprintCancer Biology